Arama

EISSN 2148-4279

EJR IS INDEXED IN WEB OF SCIENCE AND PUBMED CENTRAL

European Journal of Rheumatology

PDF

HIGHLY CITED ARTICLES

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus

Sawalha, Amr H.; Manzi, Susan.

Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg

Crayne, Courtney; Cron, Randy Q.

The emerging role of lung ultrasound in COVID-19 pneumonia

Lepri, Gemma; Orlandi, Martina; Lazzeri, Chiara; Bruni, Cosimo; Hughes, Michael; Bonizzoli, Manuela; Wang, Yukai; Peris, Adriano; Matucci-Cerinic, Marco.

Baricitinib in therapy of COPA syndrome in a 15-year-old girl

Krutzke, Sophia; Rietschel, Christoph; Horneff, Gerd.

New perspectives in the imaging of Raynaud's phenomenon

Herrick, Ariane L.; Dinsdale, Graham; Murray, Andrea.

The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis

Rosa, Irene; Romano, Eloisa; Fioretto, Bianca Saveria; Manetti, Mirko.

Pediatric Behcet's disease - clinical aspects and current concepts

Yildiz, Mehmet; Koker, Oya; Adrovic, Amra; Sahin, Sezgin; Barut, Kenan; Kasapcopur, Ozgur.

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation

Miossec, Pierre.

The impact of COVID-19 on rheumatology clinical practice and university teaching in Sydney, Australia

Cai, Ken; He, Jianna; Wong, Peter K. K.; Manolios, Nicholas.

Characteristics of coexisting localized scleroderma and inflammatory arthritis

Reiff, Daniel; Crayne, Courtney B.; Mannion, Melissa L.; Cron, Randy Q.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 3 results

Ranking

Release Date Sort Sort Article Type

The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus

Ozan Ünlü, Stephane Zuily, Doruk Erkan

(Eur J Rheumatol 2016; 3: 75-84) DOI: 10.5152/eurjrheum.2015.0085

Abstract Full Text (PDF) Related Articles

Upper extremity venous thrombosis associated with primary antiphospholipid syndrome and immunoglobulin M nephropathy in diabetes mellitus type II

Can Hüzmeli, Ferhan Candan, Ayşe Şeker Koçkara, Demet Alaygut, Mansur Kayataş

(Eur J Rheumatol 2018; 5: 145-146) DOI: 10.5152/eurjrheum.2015.0109

Abstract Full Text (PDF) Related Articles

Definition and treatment approach of non-criteria clinical manifestations of antiphospholipid syndrome

Ayten Yazıcı

(Eur J Rheumatol 2020; 7: 180-183) DOI: 10.5152/eurjrheum.2020.20099

Abstract Full Text (PDF) Related Articles